Delayed patients had 50% higher mortality (HR: 1.50), 59% higher risk of HF hospitalizations (HR: 1.59), and a nonsignificant trend toward higher risk of disabling stroke (HR: 1.25), and incurred $36,740 in additional health care costs over the 3-year follow-up period.
← all excerpts
The Clinical and Economic Consequences of Delayed Transcatheter Aortic Valve Replacement.
1
—
—